Wichtigste Fakten auf einen Blick
Schilddrüsenerkrankungen betreffen eine beträchtliche Anzahl von Menschen in unserem Land. Es wird geschätzt, dass in Polen mehr als 20% der Bevölkerung an Schilddrüsenerkrankungen leiden oder in der Vergangenheit gelitten haben. Bei Schilddrüsenerkrankungen ist es äußerst wichtig, die Krankheit schnell zu erkennen und eine angemessene Behandlung in Abhängigkeit vom Gesundheitszustand des Patienten und den Ergebnissen von Laboruntersuchungen einzuleiten. Es ist auch wichtig, dass der Patient unter ständiger Betreuung eines Endokrinologen steht [1].
Graves-Based disease
Graves-Bassed disease is an autoimmune disease of the thyroid gland. Its etiology is not well understood. It is believed that endogenous factors, including genetic and intra-intestinal factors, as well as environmental factors, are necessary for the occurrence of the disease. Autotransmitters against TSH receptors (TSHRs) are a key factor that leads to disease. They lead to the development of thyroid function.
Graves-Bassed disease is a symptom
Clinical symptoms of Graves' disease stem directly from severe hyperthyroidism: patients exhibit resting tachycardia, cardiac palpitations, nervousness, insomnia, fine hand tremors, marked heat intolerance, profuse sweating, and rapid weight loss despite an increased appetite. A pathognomonic hallmark is Graves' orbitopathy (exophthalmos, periorbital edema, and diplopia) alongside diffuse thyroid enlargement (goiter).
Graves-Bassed disease is the prognosis
In untreated hyperthyroidism, remission sometimes occurs spontaneously. However, life-threatening complications may occur early on. The use of pharmacological treatment accelerates the recovery, but in approximately 50% of cases there is a relapse of the disease. It is estimated that after 6 months of treatment, the anti-TSHR antibody levels in most patients normalize. Unfortunately, this does not give any assurance that the recovery will last.
Graves-Based Disease is a diet
Due to the accelerated hypermetabolic state in active Graves' hyperthyroidism, nutritional management initially requires an increased caloric and protein intake to counteract lean tissue wasting. Adequate calcium and vitamin D3 supplementation is vital to prevent accelerated bone resorption and secondary osteoporosis. Antioxidants (vitamins C, E, selenium) counteract intense oxidative stress. Crucially, excess dietary iodine (seaweed, kelp, iodized salt, and seafood concentrates) must be strictly avoided as iodine fuels excessive thyroid hormone synthesis.